The endocrine disrupting potential of monosodium glutamate (MSG) on secretion of the glucagon-like peptide-1 (GLP-1) gut hormone and GLP-1 receptor interaction

Global estimates of the prevalence of diabetes for 2010 and 2030

Jonathan E. Shaw, Richard Sicree, Paul Zimmet · Diabetes Research and Clinical Practice · 2009 · 7.3K citations

Medicine, Chronic Disease Prevention, Endocrinology +11

Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function

Maria Ankarcrona, Jeannette M. Dypbukt, Emanuela Bonfoco et al. · Neuron · 1995 · 1.9K citations · Full text

Life Sciences, Neurobiology, Neuroscience +14

Brain Lesions, Obesity, and Other Disturbances in Mice Treated with Monosodium Glutamate

John W. Olney · Science · 1969 · 1.8K citations

Life Sciences, Endocrinology, Neuroscience +13

Reduced Postprandial Concentrations of Intact Biologically Active Glucagon-Like Peptide 1 in Type 2 Diabetic Patients

Tina Vilsbøll, Thure Krarup, Carolyn F. Deacon et al. · Diabetes · 2001 · 884 citations · Full text

Medicine, Endocrinology, Nutrition +16

Glucose intolerance but normal satiety in mice with a null mutation in the glucagon–like peptide 1 receptor gene

Louise A. Scrocchi, Theodore J. Brown, Neil J. MacLusky et al. · Nature Medicine · 1996 · 795 citations

Medicine, Endocrinology, Genetics +15